Cargando…

A First Insight into the Genetic Diversity and Drug Susceptibility Pattern of Mycobacterium tuberculosis Complex in Zhejiang, China

In this study, our aim was to determine the predominant genotypes among the Mycobacterium tuberculosis (MTB) strains circulating in Zhejiang Province. In addition, we also sought to determine the potential associations between MTB genotypes and susceptibility to first-line drugs. Out of these isolat...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zhengwei, Pang, Yu, Chen, Songhua, Wu, Beibei, He, Haibo, Pan, Aizhen, Wang, Xiaomeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5138472/
https://www.ncbi.nlm.nih.gov/pubmed/27995145
http://dx.doi.org/10.1155/2016/8937539
_version_ 1782472070464012288
author Liu, Zhengwei
Pang, Yu
Chen, Songhua
Wu, Beibei
He, Haibo
Pan, Aizhen
Wang, Xiaomeng
author_facet Liu, Zhengwei
Pang, Yu
Chen, Songhua
Wu, Beibei
He, Haibo
Pan, Aizhen
Wang, Xiaomeng
author_sort Liu, Zhengwei
collection PubMed
description In this study, our aim was to determine the predominant genotypes among the Mycobacterium tuberculosis (MTB) strains circulating in Zhejiang Province. In addition, we also sought to determine the potential associations between MTB genotypes and susceptibility to first-line drugs. Out of these isolates, 673 (71.6%) were classified into the Beijing genotype, while the other 267 (28.4%) were from non-Beijing families. The highest proportion of Beijing genotype was found in Huzhou (80.0%) and the lowest in Lishui (48.3%). Statistical analysis revealed that there was a significant difference in the prevalence of Beijing genotype among different regions (χ (2) = 17.57, P = 0.04). In addition, the overall proportions of drug resistance to INH, RIF, SM, and EMB were 13.2% (124/940), 21.8% (75/940), 3.4% (32/940), and 5.9% (55/940) in Zhejiang, respectively. Further comparison revealed that there was no significant difference in drug susceptibility profiles between Beijing and non-Beijing strains (P > 0.05). In conclusion, we describe the genetic diversity and drug susceptibility pattern of MTB in Zhejiang for the first time. Our data demonstrate that Beijing genotype is the predominant lineage in Zhejiang, while the distribution of Beijing-genotype strains shows geographic diversity. In addition, no correlation is observed between Beijing genotype and anti-TB drug resistance.
format Online
Article
Text
id pubmed-5138472
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-51384722016-12-19 A First Insight into the Genetic Diversity and Drug Susceptibility Pattern of Mycobacterium tuberculosis Complex in Zhejiang, China Liu, Zhengwei Pang, Yu Chen, Songhua Wu, Beibei He, Haibo Pan, Aizhen Wang, Xiaomeng Biomed Res Int Research Article In this study, our aim was to determine the predominant genotypes among the Mycobacterium tuberculosis (MTB) strains circulating in Zhejiang Province. In addition, we also sought to determine the potential associations between MTB genotypes and susceptibility to first-line drugs. Out of these isolates, 673 (71.6%) were classified into the Beijing genotype, while the other 267 (28.4%) were from non-Beijing families. The highest proportion of Beijing genotype was found in Huzhou (80.0%) and the lowest in Lishui (48.3%). Statistical analysis revealed that there was a significant difference in the prevalence of Beijing genotype among different regions (χ (2) = 17.57, P = 0.04). In addition, the overall proportions of drug resistance to INH, RIF, SM, and EMB were 13.2% (124/940), 21.8% (75/940), 3.4% (32/940), and 5.9% (55/940) in Zhejiang, respectively. Further comparison revealed that there was no significant difference in drug susceptibility profiles between Beijing and non-Beijing strains (P > 0.05). In conclusion, we describe the genetic diversity and drug susceptibility pattern of MTB in Zhejiang for the first time. Our data demonstrate that Beijing genotype is the predominant lineage in Zhejiang, while the distribution of Beijing-genotype strains shows geographic diversity. In addition, no correlation is observed between Beijing genotype and anti-TB drug resistance. Hindawi Publishing Corporation 2016 2016-11-22 /pmc/articles/PMC5138472/ /pubmed/27995145 http://dx.doi.org/10.1155/2016/8937539 Text en Copyright © 2016 Zhengwei Liu et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Liu, Zhengwei
Pang, Yu
Chen, Songhua
Wu, Beibei
He, Haibo
Pan, Aizhen
Wang, Xiaomeng
A First Insight into the Genetic Diversity and Drug Susceptibility Pattern of Mycobacterium tuberculosis Complex in Zhejiang, China
title A First Insight into the Genetic Diversity and Drug Susceptibility Pattern of Mycobacterium tuberculosis Complex in Zhejiang, China
title_full A First Insight into the Genetic Diversity and Drug Susceptibility Pattern of Mycobacterium tuberculosis Complex in Zhejiang, China
title_fullStr A First Insight into the Genetic Diversity and Drug Susceptibility Pattern of Mycobacterium tuberculosis Complex in Zhejiang, China
title_full_unstemmed A First Insight into the Genetic Diversity and Drug Susceptibility Pattern of Mycobacterium tuberculosis Complex in Zhejiang, China
title_short A First Insight into the Genetic Diversity and Drug Susceptibility Pattern of Mycobacterium tuberculosis Complex in Zhejiang, China
title_sort first insight into the genetic diversity and drug susceptibility pattern of mycobacterium tuberculosis complex in zhejiang, china
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5138472/
https://www.ncbi.nlm.nih.gov/pubmed/27995145
http://dx.doi.org/10.1155/2016/8937539
work_keys_str_mv AT liuzhengwei afirstinsightintothegeneticdiversityanddrugsusceptibilitypatternofmycobacteriumtuberculosiscomplexinzhejiangchina
AT pangyu afirstinsightintothegeneticdiversityanddrugsusceptibilitypatternofmycobacteriumtuberculosiscomplexinzhejiangchina
AT chensonghua afirstinsightintothegeneticdiversityanddrugsusceptibilitypatternofmycobacteriumtuberculosiscomplexinzhejiangchina
AT wubeibei afirstinsightintothegeneticdiversityanddrugsusceptibilitypatternofmycobacteriumtuberculosiscomplexinzhejiangchina
AT hehaibo afirstinsightintothegeneticdiversityanddrugsusceptibilitypatternofmycobacteriumtuberculosiscomplexinzhejiangchina
AT panaizhen afirstinsightintothegeneticdiversityanddrugsusceptibilitypatternofmycobacteriumtuberculosiscomplexinzhejiangchina
AT wangxiaomeng afirstinsightintothegeneticdiversityanddrugsusceptibilitypatternofmycobacteriumtuberculosiscomplexinzhejiangchina
AT liuzhengwei firstinsightintothegeneticdiversityanddrugsusceptibilitypatternofmycobacteriumtuberculosiscomplexinzhejiangchina
AT pangyu firstinsightintothegeneticdiversityanddrugsusceptibilitypatternofmycobacteriumtuberculosiscomplexinzhejiangchina
AT chensonghua firstinsightintothegeneticdiversityanddrugsusceptibilitypatternofmycobacteriumtuberculosiscomplexinzhejiangchina
AT wubeibei firstinsightintothegeneticdiversityanddrugsusceptibilitypatternofmycobacteriumtuberculosiscomplexinzhejiangchina
AT hehaibo firstinsightintothegeneticdiversityanddrugsusceptibilitypatternofmycobacteriumtuberculosiscomplexinzhejiangchina
AT panaizhen firstinsightintothegeneticdiversityanddrugsusceptibilitypatternofmycobacteriumtuberculosiscomplexinzhejiangchina
AT wangxiaomeng firstinsightintothegeneticdiversityanddrugsusceptibilitypatternofmycobacteriumtuberculosiscomplexinzhejiangchina